A transdermal CRISPR/Cas9 strategy using biodegradable microneedles to target YB-1 in melanoma.

Fu X, Chen Z, Zhang Z, Jiang Y, Jiang X, Yang Y, Zhang H, Zou X, Luo J

Open source

DOI
10.1016/j.mtbio.2026.103645
Published
2026 Oct
Container
Materials today. Bio
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.mtbio.2026.103645,
  title = {A transdermal CRISPR/Cas9 strategy using biodegradable microneedles to target YB-1 in melanoma.},
  author = {Fu X and Chen Z and Zhang Z and Jiang Y and Jiang X and Yang Y and Zhang H and Zou X and Luo J},
  year = {2026},
  journal = {Materials today. Bio},
  doi = {10.1016/j.mtbio.2026.103645},
  url = {https://doi.org/10.1016/j.mtbio.2026.103645}
}

RIS

TY  - JOUR
TI  - A transdermal CRISPR/Cas9 strategy using biodegradable microneedles to target YB-1 in melanoma.
AU  - Fu X
AU  - Chen Z
AU  - Zhang Z
AU  - Jiang Y
AU  - Jiang X
AU  - Yang Y
AU  - Zhang H
AU  - Zou X
AU  - Luo J
PY  - 2026
JO  - Materials today. Bio
DO  - 10.1016/j.mtbio.2026.103645
UR  - https://doi.org/10.1016/j.mtbio.2026.103645
ER  - 

APA

X, F., Z, C., Z, Z., Y, J., X, J., Y, Y., H, Z., X, Z., & J, L. (2026). A transdermal CRISPR/Cas9 strategy using biodegradable microneedles to target YB-1 in melanoma.. Materials today. Bio. https://doi.org/10.1016/j.mtbio.2026.103645

Source records